Trial intelligence / Profile preview

Monodisperse Fluticasone Propionate Aerosols in Asthma

NCT01662778Phase 4Completed

Sponsor
Imperial College London
Start
Dec 2011
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of fluticasone propionate in asthma (4 arms), sponsored by Imperial College London. Primary endpoint: Adenosine Monophosphate Challenge Test PC20 at 2 hours. Started Dec 2011; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01662778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01662778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call